Clinical trial NCT01077102: Eccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD)
Official title: Eccentric Training as Novel Rehabilitation for COPD
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Pulmonary Disease, Chronic Obstructive
Bronchitis, Chronic
Emphysema
Keywords: COPD
eccentric exercise training
cycle ergometer
muscle function
Lead sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sponsor class: OTHER
First posted: 2010-02-26
Enrollment: 24
Sex: MALE
Minimum age (years): 40
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The main purpose of this project is to establish the additional value of eccentric versus concentric exercise to optimize muscle function in patients with severe COPD. With this pilot project the investigators expect that an eccentric endurance training protocol adapted to severe COPD patients will lead to gains in muscle strength, the primary outcome, and cellular adaptation (muscle morphology and oxidative capacity, mitochondrial respiratory capacity) when compared to a concentric training approach.

This information will be essential if the investigators want to design and power a randomized clinical trial that will allow assessing effectiveness of this novel rehabilitation approach.

Detailed description: Chronic obstructive pulmonary disease (COPD) is a major respiratory illness that is both preventable and treatable. Dyspnea is the most important symptom that COPD patients experience and this can have a major impact on their daily live. While COPD is characterized by a spectrum of disease severity, most patients experience poor exercise intolerance attributable to ventilatory limitation as well as peripheral muscle fatigue, ultimately leading to severe disability.

Endurance exercise is an important component of pulmonary rehabilitation and is aimed at preventing this decline in functional capacity. The effects of pulmonary rehabilitation are largely attributable to the exercise training component involving concentric muscle contractions, traditionally trough dynamic, large muscle exercise on a cycle ergometer or treadmill. However, many patients are unable to partake and benefit from such rehabilitation because of locomotor muscle weakness and severe ventilatory limitation that prevent them from exercising at intensities sufficient to provoke improvements in cardioventilatory and skeletal muscle function. Eccentric exercise is known for its unique physiologically fundamental characteristics: the lower metabolic demand for a same power output and greater muscle gains compared to the concentric exercise. For this reason, eccentric endurance training has been proposed as a novel adjunctive rehabilitative countermeasure for certain chronic diseases (such as coronary disease and COPD) and can play an important role for patients with advanced disease.

Eligibility criteria: Inclusion Criteria:

* male patients with severe COPD (FEV1/FVC \< 0.70 and FEV1 ≤ 50% predicted of normal)
* Patients aged 40 to 80 years old in whom exercise is not contraindicated
* Current and ex-smokers
* Patients who do not require oxygen therapy

Exclusion Criteria:

* Patients presenting neurological or orthopedic problems, morbid obesity, acute medical condition or recent exacerbations (in the last four weeks)
* Patients with recent or current participation in a rehabilitation program

Primary outcomes:
measure: Muscle strength
timeFrame: At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program
Secondary outcomes:
measure: Muscle cellular adaptation
timeFrame: At baseline and at the end of the training program
measure: Exercise capacity (maximal and submaximal)
timeFrame: At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program
measure: Physical Activity
timeFrame: At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program
measure: Health-related quality of life (HRQL)
timeFrame: At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program
measure: Muscle pain and creatine kinase(CK)levels
timeFrame: Muslce pain will be assessed in the beginning and in the end of each session and CK levels at baseline, after the fisrt week of training, midway through and the after the last week of training
Other outcomes:
Locations:
city: Montreal
country: Canada
facility: Montreal Chest Institute
state: Quebec
Study officials:
affiliation: McGill University Health Centre/Research Institute of the McGill University Health Centre
name: Jean Bourbeau, M.D, M.Sc.
role: PRINCIPAL_INVESTIGATOR
affiliation: McGill University Health Centre/Research Institute of the McGill University Health Centre
name: Tanja Taivassalo, Ph.D.
role: PRINCIPAL_INVESTIGATOR
affiliation: McGill University Health Centre/Research Institute of the McGill University Health Centre
name: Helene Perrault, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References: